Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
SSE:603896.SS
22.31 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 691.684 | 784.347 | 829.072 | 767.137 | 636.051 | 546.759 | 511.452 | 369.963 | 314.88 | 301.912 | 301.592 | 253.03 | 177.753 |
| Kosten van de omzet
| 133.347 | 135.528 | 129.207 | 126.373 | 105.672 | 85.407 | 72.063 | 50.929 | 47.576 | 57.467 | 82.153 | 87.861 | 76.385 |
| Brutowinst
| 558.336 | 648.819 | 699.864 | 640.765 | 530.379 | 461.352 | 439.389 | 319.035 | 267.304 | 244.446 | 219.439 | 165.169 | 101.368 |
| Brutowinstmarge
| 0.807 | 0.827 | 0.844 | 0.835 | 0.834 | 0.844 | 0.859 | 0.862 | 0.849 | 0.81 | 0.728 | 0.653 | 0.57 |
| Onderzoek- en ontwikkelingskosten
| 36.597 | 49.683 | 47.824 | 50.825 | 48.485 | 39.419 | 33.667 | 20.969 | 17.81 | 17.948 | 20.55 | 12.701 | 9.002 |
| Algemene en administratieve kosten
| 37.686 | 43.932 | 37.19 | 35.672 | 44.994 | 58.977 | 53.094 | 18.388 | 12.445 | 12.011 | 13.911 | 33.11 | 23.373 |
| Verkoop- en marketingkosten
| 229.484 | 316.794 | 319.375 | 319.757 | 264.018 | 233.653 | 236.499 | 178.564 | 138.793 | 128.065 | 103.84 | 72.716 | 44.735 |
| Verkoop-, algemene en administratieve kosten
| 267.17 | 360.726 | 356.565 | 355.429 | 309.012 | 292.63 | 289.593 | 196.952 | 151.238 | 140.076 | 117.751 | 105.826 | 68.108 |
| Overige kosten
| 79.305 | -58.156 | 28.116 | 34.555 | 16.684 | 15.318 | -0.217 | -2.046 | 9.94 | 5.259 | 3.232 | 2.369 | 4.102 |
| Bedrijfskosten
| 383.073 | 394.097 | 432.505 | 440.809 | 374.181 | 347.367 | 339.957 | 233.312 | 191.366 | 181.084 | 155.423 | 107.374 | 68.96 |
| Bedrijfsresultaat
| 175.263 | 254.722 | 280.878 | 207.153 | 158.904 | 127.774 | 110.305 | 90.837 | 71.012 | 57.495 | 66.446 | 52.651 | 30.83 |
| Bedrijfsresultaat ratio
| 0.253 | 0.325 | 0.339 | 0.27 | 0.25 | 0.234 | 0.216 | 0.246 | 0.226 | 0.19 | 0.22 | 0.208 | 0.173 |
| Totaal overige inkomsten en kosten netto
| -0.536 | 0.189 | -2.913 | -6.093 | -5.202 | -2.78 | -0.217 | -2.046 | 9.94 | 5.127 | 3.083 | 2.369 | 2.489 |
| Inkomen voor belasting
| 174.727 | 254.911 | 277.966 | 201.061 | 153.702 | 124.994 | 110.088 | 88.791 | 80.927 | 62.623 | 69.529 | 55.02 | 34.898 |
| Inkomen voor belasting ratio
| 0.253 | 0.325 | 0.335 | 0.262 | 0.242 | 0.229 | 0.215 | 0.24 | 0.257 | 0.207 | 0.231 | 0.217 | 0.196 |
| Belastingkosten
| 0.013 | 0.431 | 0.453 | 0.749 | 1.99 | 1.099 | 2.435 | -0.089 | -0.051 | -0.021 | 0.278 | 0.972 | 0.875 |
| Nettowinst
| 174.715 | 254.48 | 277.783 | 200.827 | 151.712 | 123.895 | 107.653 | 88.88 | 80.978 | 62.644 | 69.251 | 54.048 | 34.023 |
| Nettowinstmarge
| 0.253 | 0.324 | 0.335 | 0.262 | 0.239 | 0.227 | 0.21 | 0.24 | 0.257 | 0.207 | 0.23 | 0.214 | 0.191 |
| WPA (Winst Per Aandeel)
| 0.88 | 1.3 | 1.44 | 1.04 | 0.82 | 0.68 | 0.59 | 0.55 | 0.59 | 0.46 | 0.51 | 0.4 | 0.32 |
| Verwaterde WPA
| 0.88 | 1.3 | 1.44 | 1.04 | 0.82 | 0.68 | 0.58 | 0.55 | 0.59 | 0.46 | 0.51 | 0.4 | 0.32 |
| EBITDA
| 268.489 | 379.576 | 372.706 | 278.359 | 220.733 | 175.668 | 158.288 | 131.162 | 202.545 | 98.54 | 87.546 | 60.975 | 33.671 |
| EBITDA ratio
| 0.388 | 0.484 | 0.45 | 0.363 | 0.347 | 0.321 | 0.309 | 0.355 | 0.643 | 0.326 | 0.29 | 0.241 | 0.189 |